we are committed to delivering innovative solutions that drive growth and add value to our clients. With a team of experienced professionals and a passion for excellence.
While influenza continues to have high to very high activity across the vast majority of the U.S., we are seeing a flattening, which has
From heavy metals and chemical residues to repercussions from produce contamination and infant formula adulteration and shortages, 2022 became a year of regulatory embarrassment
While cases of influenza, COVID, and RSV continue to be high across the U.S., the rate of increase appears to have slowed. We are
In a previous article, we noted the focus that federal regulators had begun placing on the retail food industry, and the latest Guidance Document
Not only is influenza (“the flu”) continuing to spread across the U.S., but its reach has also extended across the entirety of the United
Evaluations of FDA’s performance and programs are nothing new. Just this year, the agency has been the subject of reviews by Congress, GAO, AFDO,
Despite the results of November’s state elections which resulted in two more states having legalized adult-use cannabis. The passage of amendments in Maryland and
The U.S. is continuing to see increasing levels of flu cases and hospitalizations. In fact, according to CDC, the hospitalizations are the highest they
With food labels being the primary source of information on a product’s ingredients – particularly for those who have food allergies – FDA issued
© 2026 The Acheson Group. All rights reserved
